Results 181 to 190 of about 117,406 (297)
Bypass surgery in a Jehovah's Witness with critical limb ischemia and end stage renal disease: a case report. [PDF]
Choi E.
europepmc +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Measurement-device-independent continuous variable entanglement witness in a quantum network. [PDF]
Fu J, Wang X, Liu S, Jing J.
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
“Can Only the Dead Speak?” Terror, Trauma and the Witness Traveller [PDF]
Minoli Salgado
openalex +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Management Challenges of Life-Threatening Thrombosis and Hemorrhage in a Jehovah's Witness Patient With Hereditary Hemorrhagic Telangiectasia: A Case Report. [PDF]
Naeem A, Mangrio SM, Azhar A, Khan U.
europepmc +1 more source
Bleeding in a Jehovah’s Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate [PDF]
James A. Robblee +4 more
openalex +1 more source

